about
Substituted methcathinones differ in transporter and receptor interactionsDisease-toxicant interactions in Parkinson's disease neuropathologyNeurotoxicity of methamphetamine and 3,4-methylenedioxymethamphetamineRecombinant AAV8-mediated intrastriatal gene delivery of CDNF protects rats against methamphetamine neurotoxicityMethamphetamine abuse affects gene expression in brain-derived microglia of SIV-infected macaques to enhance inflammation and promote virus targetsChronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits.Oxidative and nitrative stress in neurodegeneration.The role of dopamine receptors in the neurotoxicity of methamphetamine.Development of in vivo drug-induced neurotoxicity models.Methamphetamine causes degeneration of dopamine cell bodies and terminals of the nigrostriatal pathway evidenced by silver staining.D1 but not D4 dopamine receptors are critical for MDMA-induced neurotoxicity in mice.Fragment C Domain of Tetanus Toxin Mitigates Methamphetamine Neurotoxicity and Its Motor Consequences in Mice.Electroacupuncture Promotes Recovery of Motor Function and Reduces Dopaminergic Neuron Degeneration in Rodent Models of Parkinson's Disease.Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors.A Single Neonatal Exposure to BMAA in a Rat Model Produces Neuropathology Consistent with Neurodegenerative Diseases.Neuroprotective potential of curcumin in combination with piperine against 6-hydroxy dopamine induced motor deficit and neurochemical alterations in rats.L-DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum.Simvastatin Inhibits Activation of NADPH Oxidase/p38 MAPK Pathway and Enhances Expression of Antioxidant Protein in Parkinson Disease Models.
P2860
Q28288908-29D5FBE9-E4CD-4DA0-81B1-DC4B8D1CCC19Q29248297-6F2C644D-5F1B-443A-BF0C-BEB4416B2697Q30417935-DBE74AA2-3A39-4A34-8F45-FF56DFBAF07CQ33702977-42EB2F82-907C-4F03-AEEF-7658A972CFF0Q35997428-505FA51C-79D5-4409-93D3-364D4409FE92Q36316462-D13228D5-6A85-4117-B3E0-93E76F044AECQ36326881-16CA9076-34C2-4718-AB4B-66E73AC90A4EQ38100197-FFDAA836-3FD0-40BA-B7E8-C6E0A97DD22BQ38259808-2A2C7676-5EB7-4A87-8387-F5D5475C8CABQ38309143-B5384F08-22C9-4EA0-95DE-BE7F4EE8D3E5Q40227540-456712B4-0019-498E-ADF4-6C98EB15B85BQ40983371-8D339A68-8AF9-4D68-B50F-768B87A2F087Q41661302-D097C0C2-C894-4BEF-B88F-4CFDAF86C2D2Q42220091-0AB190F0-F937-4A87-B962-77A9888A4983Q47891276-38B75D84-A2F0-4FE6-8279-9E254539A1C9Q48427564-2C249CA6-3C7D-4168-822E-4329C11F4CF8Q48843863-2F1F2933-5974-4E04-9740-F8C02B868387Q54976937-FA727726-0A01-44EA-A12E-B360BF41DE83
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Methamphetamine and Parkinson's disease.
@en
type
label
Methamphetamine and Parkinson's disease.
@en
prefLabel
Methamphetamine and Parkinson's disease.
@en
P2860
P356
P1433
P1476
Methamphetamine and Parkinson's disease.
@en
P2093
Noelia Granado
Sara Ares-Santos
P2860
P304
P356
10.1155/2013/308052
P577
2013-02-07T00:00:00Z